Anxiety :: Now anxious people can counsel themselves
People suffering from anxiety disorders can help themselves using approaches based on cognitive behavioral therapies, according to a new book by a University of Manchester psychologist.
People suffering from anxiety disorders can help themselves using approaches based on cognitive behavioral therapies, according to a new book by a University of Manchester psychologist.
Treatment with intravenous bisphosphonates — drugs used to reduce harm done to bones by cancer or cancer therapy — increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found.
Why does putting our feelings into words ? talking with a therapist or friend, writing in a journal ? help us to feel better” A new brain imaging study by UCLA psychologists reveals why verbalizing our feelings makes our sadness, anger and pain less intense.
Men are 12 times more likely than women to sustain severe human bite injuries for which surgery may be necessary, according to a study published in the July issue of the Emergency Medicine Journal.
In a survey of more than one thousand infertility patients with frozen embryos, 60 percent of patients report that they are likely to donate their embryos to stem cell research, a level of donation that could result in roughly 2000 to 3000 new embryonic stem cell lines.
Consultation seeks to stimulate debate on New Deal for Carers. Details of a huge national debate on how to improve the future of the nation’s six million carers were released today by Care Services Minister, Ivan Lewis.
An examination of Medicare Part D plans in California and Hawaii reveals wide variations in drug formularies, but indicates that for many classes of drugs, it is possible to find at least one or more drug that is covered by nearly all Part D plans, according to a study in the June 20 issue of JAMA.
New research, revealing the true extent of abuse suffered by older people in the UK, was released today by Comic Relief, Chief Executive, Kevin Cahill and Health Minster, Ivan Lewis.
Scientists have found a novel signaling pathway in cells that is altered by genetic mutations recently identified in Parkinson disease development. These new findings show how the mutations affect cellular function and could provide a target for drug therapies to treat the disease.
The U.S. Food and Drug Administration (FDA) approved Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension, a rare, life-threatening condition characterized by continuous high blood pressure within the arteries of the lungs.